Estimation of Outcome and Quality of Life in ECMO Patients
Recruiting
Observational Study
Extracorporeal Membrane Oxygenation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Heinrich-Heine University, Duesseldorf · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The availability as well as the use of extracorporeal membrane oxygenation (ECMO) systems for severe acute respiratory or cardiocirculatory failure is steadily increasing. The decision to initiate ECMO therapy is predominantly made in emergency situations, for which the focus is on acute survival. The decisions if a patient will profit from ECMO therapy are mainly made from clinical experience and…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age ≥ 18 years
* start of ECMO therapy ≤24h
* written informed consent from patient or health-care proxy
Exclusion Criteria:
* age \< 18 years
* Language barrier (communication in German/local language or English not possible).
* no ECMO therapy or ECMO therapy longer than 2…
Contacts